NSE filing, NSE: PNBHOUSING. Summary written from the filing by ALFA Finder's alert engine.
PNB Housing Finance Ltd: key numbers
- Share price
- ₹1,122.00
- Market cap
- ₹29,262 Cr
- Revenue (annual)
- ₹8,505 Cr
- Net profit (annual)
- ₹2,291 Cr
- P/E (TTM)
- 12.6×Sector 19.7×
- Promoter holding
- 28.01%-0.02% QoQ
- FII holding
- 14.19%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from PNB Housing Finance Ltd
All →PNB Housing Finance Investor Presentation: Key Takeaways
Q2 FY27: PAT INR 617 cr (+6% YoY), loan book INR 95,079 cr (+19% YoY), NIM 3.67%, GNPA 0.91%. Strategy shifts toward high-yield Affordable and Emerging Markets segments.
PNB Housing Finance Q2 FY27 Results: Net Profit ₹616.5 Cr, Up 6.0% YoY
PNB Housing Finance Ltd reported revenue from operations of ₹2,423 Cr (+13.9% YoY) and net profit of ₹616.5 Cr (+6.0% YoY) for Q2 FY27.
- Key figure
- Net profit ₹616.5 Cr · +6.0% YoY
PNB Housing Finance Debt & Borrowing: ₹800 Cr
PNB Housing Finance redeemed commercial paper series CP-534A in full at maturity on 27 October 2026. The redemption amount was Rs 800 Crore.
- Value
- ₹800.0 Cr
PNB Housing Finance Debt & Borrowing: ₹22.29 Cr
PNB Housing Finance paid Rs.22.29 Crore annual interest on Series LXXI NCDs on the due date. Timely payment was confirmed under Regulation 57 with no delay.
- Value
- ₹22.29 Cr
PNB Housing Finance Debt & Borrowing: ₹253.7 Cr
PNB Housing Finance allotted 25,365 secured NCDs at 8.4552% p.a. via private placement. The issue raises ₹253.65 Crore over a 5-year tenure maturing October 2031.
- Value
- ₹253.7 Cr
- Execution
- 5 Years
PNB Housing Finance Other Announcement
PNB Housing Finance submitted its quarterly shareholding pattern for the period ended September 30, 2026. This is a standard regulatory compliance filing.
Other other announcement announcements
All →Aarti Pharmalabs Other Announcement
Aarti Pharmalabs has intimated under Regulation 46 that it revamped its website at the existing URL to improve design and accessibility. The notice has no financial or business substance.
Sagarsoft (India) Other Announcement
Sagarsoft (India) filed its Regulation 32 fund utilisation statement for its 2021 preferential issue. No deviation was reported and the full Rs.5.08 Crore was used.
Sadhana Nitro Chem Other Announcement
Sadhana Nitro Chem reported no deviation in use of its preferential issue proceeds for the quarter ended September 2026. The Audit Committee reviewed the statement.
Shriram Asset Management Company Other Announcement
Shriram AMC filed ICRA's quarterly monitoring agency report on preferential issue proceeds. Utilisation is in line with the offer objects, with no deviation reported.
Jhandewalas Foods Other Announcement
Jhandewalas Foods filed its quarterly shareholding pattern for the period ended September 30, 2026. The filing records holdings by category and contains no transaction or money event.
Avience Biomedicals Other Announcement
Avience Biomedicals confirmed corporate governance compliance is not applicable, as it is SME-listed on NSE Emerge. No quarterly governance report is required for September 2026.